Zobrazeno 1 - 10 of 46 pro vyhledávání: '"Upton AM"'
1
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters
Autor: Li P, Fu L, Zheng M, Zhao W, Yu Lu, Jin H, Upton Am, Zhu H, Xu J, B. Wang, Mdluli K
Publikováno v: The International Journal of Tuberculosis and Lung Disease. 16:1119-1125
OBJECTIVE To assess the activity of clofazimine (CFZ) against Mycobacterium tuberculosis persisters using an oxygen depletion model and a low-dose aerosol mouse model of chronic tuberculosis (TB). DESIGN In in vitro experiments, CFZ showed much bette
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ffc9ce8048f3cb6f8e16af8df9e7222
https://doi.org/10.5588/ijtld.11.0752
Zobrazit plný text záznamu
2
'Soothing the ring of fire': Australian women's and midwives' experiences of using perineal warm packs in the second stage of labour
Autor: Dahlen, HG, Homer, CSE, Cooke, M, Upton, AM, Nunn, RA, Brodrick, BS
Objective: to determine women's and midwives' experiences of using perineal warm packs in the second stage of labour. Design: as part of a randomised controlled trial (Warm Pack Trial), women and midwives were asked to complete questionnaires about t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______363::6ca771287d9ae3a9e2b899f619c43180
https://hdl.handle.net/10453/9445
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Perineal outcomes and maternal comfort related to the application of perineal warm packs in the second stage of labor: a randomized controlled trial.
Autor: Dahlen HG, Homer CS, Cooke M, Upton AM, Nunn R, Brodrick B
Publikováno v: Birth: Issues in Perinatal Care; Dec2007, Vol. 34 Issue 4, p282-290, 9p
Zobrazit plný text záznamu
8
Akademický článek
Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.
Autor: Li S-Y; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tyagi S; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Soni H; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Betoudji F; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Converse PJ; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Mdluli K; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Upton AM; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Fotouhi N; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Barros-Aguirre D; Global Health Medicines R&D, GlaxoSmithKline R&D Limited, Tres Cantos, Madrid, Spain., Ballell L; Global Health Medicines R&D, GlaxoSmithKline R&D Limited, Tres Cantos, Madrid, Spain., Jimenez-Navarro E; Global Health Medicines R&D, GlaxoSmithKline R&D Limited, Tres Cantos, Madrid, Spain., Nuermberger EL; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Apr 03; Vol. 68 (4), pp. e0156223. Date of Electronic Publication: 2024 Feb 20.
Zobrazit plný text záznamu
9
Akademický článek
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis .
Autor: Jeffreys LN; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Ardrey A; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Hafiz TA; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Dyer LA; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Warman AJ; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Mosallam N; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Nixon GL; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Fisher NE; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Hong WD; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Leung SC; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Aljayyoussi G; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Bibby J; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Almeida DV; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland21205, United States., Converse PJ; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland21205, United States., Fotouhi N; Global Alliance for TB Drug Development, New York, New York10005, United States., Berry NG; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Nuermberger EL; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland21205, United States., Upton AM; Global Alliance for TB Drug Development, New York, New York10005, United States.; Evotec (US) Inc., 303B College Road East, Princeton, New Jersey08540, United States., O'Neill PM; Department of Chemistry, University of Liverpool, LiverpoolL69 7ZD, U.K., Ward SA; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K., Biagini GA; Centre for Drugs and Diagnostics, Department of Tropical Infectious Diseases, Liverpool School of Tropical Medicine, Pembroke Place, LiverpoolL3 5QA, U.K.
Publikováno v: ACS infectious diseases [ACS Infect Dis] 2023 Feb 10; Vol. 9 (2), pp. 221-238. Date of Electronic Publication: 2023 Jan 06.
Zobrazit plný text záznamu
10
Akademický článek
The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
Autor: Gordon O; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Dikeman DA; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Ortines RV; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Wang Y; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Youn C; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Mumtaz M; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Orlando N; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Zhang J; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Patel AM; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA., Gough E; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Kaushik A; Center for Tuberculosis Research, Johns Hopkins Universitygrid.471401.7grid.21107.35grid.471401.7, Baltimore, Maryland, USA., Nuermberger EL; Center for Tuberculosis Research, Johns Hopkins Universitygrid.471401.7grid.21107.35grid.471401.7, Baltimore, Maryland, USA., Upton AM; Evotec (US) Inc., Princeton, New Jersey, USA., Fotouhi N; TB Alliance, New York, New York, USA., Miller LS; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.; Immunology, Janssen Research and Development, Spring House, Pennsylvania, USA., Archer NK; Department of Dermatology, Johns Hopkins University School of Medicinegrid.471401.7, Baltimore, Maryland, USA.
Publikováno v: Microbiology spectrum [Microbiol Spectr] 2022 Oct 26; Vol. 10 (5), pp. e0245121. Date of Electronic Publication: 2022 Sep 15.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje